Clinical guideline for psychedelics

The Clinical Practice Guideline for the Appropriate Use of Methylenedioxymethamphetamine-assisted psychotherapy for PTSD was approved by Australia’s National Health and Medical Research Council. It is the world’s 1st related to MDMA-AP to use the Grading of Recommendations Assessment, Development and Evaluation approach.